fb_script

Insulin pump with predictive low glucose management function reduces hypoglycaemia exposure in young people with type 1 diabetes

A T1DCRN funded clinical trial published in Diabetes Care has shown that a pump with the ability to suspend insulin delivery when blood glucose levels begin to fall can reduce hypoglycaemic episodes without deterioration in glycaemic control.

Members of the PLGM study team L-R: Dr Mary Abraham, Prof Tim Jones, Dr Charles Czank, Prof Liz Davis and Ms Jennifer Nicholas

The integration of real-time continuous glucose monitoring systems and pump therapy has been an important milestone in the management of type 1 diabetes, and advances in the technology field offers the potential to further improve clinical outcomes.

Read More

A new individualised approach to severe hypoglycaemia

T1DCRN researcher Professor Thomas Kay from St Vincent’s Institute in Melbourne and an international team of specialists have developed a new four-stage treatment plan to tackle problematic hypoglycaemia.

fingerprick

Severe hypoglycaemia is experienced by a third of people with type 1 diabetes at least once per year, when they will require another person to assist them in recovery. Severe hypoglycaemia can usually be explained by exercise, alcohol or errors in insulin dose, but in some people it is unpredictable and can occur seemingly without explanation.  This problematic hypoglycaemia has significant impacts on health and quality of life, but can be difficult to treat. Read More